Chronic Diseases And Translational Medicine: Impact Factor, Indexing, Publication Time & Fees


The Chronic Diseases And Translational Medicine is reputed journal publishes research related to Medicine (miscellaneous) (Q2). The ISSN of the journal is .

Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.

Chronic Diseases And Translational Medicine: Details

Journal TitleChronic Diseases and Translational Medicine
PublisherJohn Wiley and Sons Inc
Publication CountryUnited States
ISSN2095882X
Publication AreaMedicine
Publication LanguageENG
Review ProcessDouble anonymous peer review
Scopus IndexedYes

Journal Quartile

The Chronic Diseases And Translational Medicine is ranked in Q2.

Indexing

The Chronic Diseases And Translational Medicine is indexed in: DOAJ.

Publication Fee

There is a fee to publish in the Chronic Diseases And Translational Medicine. The publication fee is 2298 EUR; 1949 GBP; 2650 USD.

The journal also offers a fee waiver policy.

Publication Time

The Chronic Diseases And Translational Medicine takes an average of 14 weeks to publish research papers.

Journal Official Website

The official website of the journal is https://onlinelibrary.wiley.com/journal/25890514.

Please visit only official website of the journal to submit research papers.



Similiar journals to publish


Chronic Diseases and Translational Medicine
ISSN:
Publisher: John Wiley and Sons Inc
Journal Scope: Medicine (miscellaneous) (Q2)

Chronic Diseases and Injuries in Canada
ISSN: 19256515
Publisher: Public Health Agency of Canada
Journal Scope:

Chronic Obstructive Pulmonary Diseases
ISSN:
Publisher: COPD Foundation
Journal Scope: Pulmonary and Respiratory Medicine (Q2)

Chronic Diseases in Canada
ISSN: 2288699
Publisher: Public Health Agency of Canada
Journal Scope:

Journal of Chronic Diseases
ISSN: 219681
Publisher: Pergamon Press Ltd.
Journal Scope:

Chronic Diseases Journal
ISSN: 2588-7297
Publisher: Vesnu Publications
Journal Scope: chronic, diseases, patient education, subacute diseases, policy making